Viking Therapeutics, Inc. (VKTX)

28.34 -0.17 (-0.60%) USD  |  NASDAQ  |  Oct 12, 16:00
28.29 -0.05 (-0.18%) After-Hours: 20:00
More

Viking Therapeutics CFO to Sales (TTM)

CFO to Sales (TTM) Chart

View CFO to Sales (TTM) for VKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical CFO to Sales (TTM) Data

View and export this data back to . Start Trial.
Date Value

CFO to Sales Definition

The Cash From Operations to Sales is a ratio that tells investors how capable a company is of generating cash from sales.

Read full definition.

CFO to Sales (TTM) Range, Past 5 Years

View CFO to Sales (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CFO to Sales (TTM) Benchmarks

View CFO to Sales (TTM) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Amgen, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade